학술논문
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study
Document Type
Article
Author
Kim, S.; Borg, C.; Bibeau, F.; Meurisse, A.; Vernerey, D.; Garcia, M.-L.; Ghiringhelli, F.; de la Fouchardière, C.; Evesque, L.; Smith, D.; Badet, N.; Samalin, E.; Lopez-Trabada Ataz, D.; Parzy, A.; Desramé, J.; Baba Hamed, N.; Buecher, B.; Tougeron, D.; Bouché, O.; Dahan, L.; Chibaudel, B.; El Hajbi, F.; Mineur, L.; Dubreuil, O.; Ben Abdelghani, M.; Pecout, S.; Herfs, M.; Taïeb, J.
Source
In: The Lancet Oncology . (The Lancet Oncology, April 2024, 25(4):518-528)
Subject
Language
English
ISSN
14745488
14702045
14702045